Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07653776 · ClinicalTrials.gov registry record · NA
Radicle GI Health RAATM: A Study Assessing the Impact of Health and Wellness Products on Gastrointestinal-Related Quality of Life and Related Health Outcomes
A NA study, sponsored by Radicle Science.
- Not yet
- Registry status
- NA
- Development phase
- 550
- Enrollment target
NCT07653776: Clinical Trial NA study, sponsored by Radicle Science.
NCT07653776 is a NA study that has not yet begun recruiting, run by Radicle Science. The registered enrollment target is 550 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07653776, a NA study, has not yet begun recruiting, sponsored by Radicle Science.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 550 participants
- Enrollment target
Study Summary
Radicle GI Health RAA: A randomized, double-blind, placebo- controlled direct-to-consumer study assessing the impact of health and wellness products on gastrointestinal-related quality of life and related health outcomes.
Primary Outcome
Change in GI-related Quality of Life (QOL): Difference between rates of change over time in GI-related QOL as assessed by Digestion-associated Quality of Life Questionnaire (scale 0-9; where the higher scores correspond to worse GI-related quality of life)
Interventions
- DIETARY_SUPPLEMENT Placebo GI Health Control
- DIETARY_SUPPLEMENT Active GI Health Product 1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2026-06-12 |
| Est. Completion | 2027-06-12 |
| Phase | NA |
What is known before NCT07653776 opens enrollment
NCT07653776 is an interventional study that assigns participants to a tested intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo GI Health Control is the first listed.
NCT07653776 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07653776 about?
NCT07653776 is a clinical study titled "Radicle GI Health RAATM: A Study Assessing the Impact of Health and Wellness Products on Gastrointestinal-Related Quality of Life and Related Health Outcomes". Radicle GI Health RAA: A randomized, double-blind, placebo- controlled direct-to-consumer study assessing the impact of health and wellness products on gastrointestinal-related quality of life and related health outcomes.
What is the current status of trial NCT07653776?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 550 participants. The study started on 2026-06-12. Estimated completion is 2027-06-12.
What interventions are being tested in trial NCT07653776?
The interventions under investigation include: Placebo GI Health Control (DIETARY_SUPPLEMENT), Active GI Health Product 1 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07653776?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07653776's enrollment target sits among peer trials
550 184th of 2000 higher than 1,815 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
- NCT03474913 · 550 participants
Upright MRI for Prostate Cancer Screening
- NCT04761120 · 550 participants
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI